# FDA recall D-0391-2025

> **Preferred Pharmaceuticals, Inc.** · Class II · drug recall initiated 2025-04-18.

## Product

Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.

## Reason for recall

cGMP Deviations

## Distribution

Nationwide in the US

## Key facts

- **Recall number:** D-0391-2025
- **Recalling firm:** Preferred Pharmaceuticals, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-04-18
- **Report date:** 2025-05-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Anaheim, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0391-2025

## Citation

> AI Analytics. FDA recall D-0391-2025. Retrieved 2026-07-05 from https://api.ai-analytics.org/recall/D-0391-2025. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*